retatrutide parkinson's disease trial parkinson Dr. Robert Hauser, Director of the USF Health retatrutide parkinson clinical trial retatrutide

If you switched injection sites, switched pen brands, or had a batch of compounded medication that was off-spec, you might be getting less drug than before

Omatseye Jr., MD, aesthetic and regenerative medicine provider at Signature Rejuvenation MD in Florida, says your sex, body weight, and age wont change the timeline, but any medication or health condition (e.g., severe renal failure) that decreases Wegovys breakdown in the body will make it take longer

Al-Aly and colleagues found a beneficial relationship between the continuous use of GLP-1s and fewer cardiovascular events

Accessed June 14, 2025, through: Methionine Professional Monograph

But what if the key to optimizing your GLP-1 therapy lies in strategic addition rather than elimination